Gut Microbiome Characteristics and Neurodevelopmental Functioning in Children With Autism Spectrum Disorder
Starting soon
Conditions studied: Autism Spectrum Disorder
In brief
Autism Spectrum Disorder (ASD) is a neurodevelopmental condition that affects communication, behavior, sensory processing, and daily functioning. Recent research suggests that the gut microbiome, the community of microorganisms living in the gastrointestinal tract, may influence brain development and function through the gut-brain and gut-motor axes. Alterations in gut microbiome characteristics have been reported in children with ASD and may be associated with differences in neurodevelopmental outcomes. This observational study aims to investigate the association between gut microbiome characteristics and neurodevelopmental functioning in children with ASD. The study will evaluate multiple domains of functioning, including motor performance, sensory processing, behavior, cognition, sleep, and participation in daily activities. Gut microbiome characteristics will be assessed using stool sample analysis, and neurodevelopmental outcomes will be measured using standardized assessments and validated questionnaires. The findings of this study may improve understanding of the relationship between the gut microbiome and neurodevelopmental functioning in children with ASD and provide insights into the role of the gut-motor axis in shaping functional outcomes. This knowledge may support future research and contribute to the development of more personalized approaches to assessment and rehabilitation in ASD.
Key facts
- Study ID
- NCT07646808
- Run by
- Saveetha University
- People needed
- 600
- Starts
- 2026-07-01
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-06-16
Who can join
Age: 3 and older, up to 12. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Children aged 3 to 12 years
- Clinical diagnosis of Autism Spectrum Disorder (ASD) according to DSM-5/ICD criteria and confirmed from medical records or specialist assessment
- Stable clinical status at the time of enrollment
- Parent/legal guardian willing to provide written informed consent
- Child able to undergo stool sample collection and neurodevelopmental assessments
- Parent/caregiver able to complete questionnaires and provide dietary and medical history
You may not qualify if…
- Use of systemic antibiotics, probiotics, prebiotics, synbiotics, or bowel-cleansing agents within the previous 4-12 weeks before stool collection
- Presence of acute gastrointestinal infection or acute febrile illness at the time of assessment
- Known chronic gastrointestinal disorders that may independently alter the gut microbiome, such as inflammatory bowel disease, celiac disease, short bowel syndrome, or chronic intestinal malabsorption
- Major neurological, genetic, or metabolic disorders other than ASD that may independently affect neurodevelopment
- Current use of medications known to significantly affect gut microbiota or bowel motility, if clinically relevant to your protocol
- Inability to provide stool sample or complete the required assessments
- Refusal of consent by parent/legal guardian
Where it is running
- Saveetha Medical College and Hospital — Chennai, Tamil Nadu, India
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.